Articles published by CDR-Life

CDR-Life Announces CDR609 as New T-Cell Engager Clinical Candidate Targeting LGR5, a Highly Cancer-specific Surface Antigen Widely Expressed on Common Solid Tumor

June 26, 2025

From CDR-Life

Via Business Wire

CDR-Life Appoints Pascal Touchon to the Board of Directors to Support Continued Growth and Advancement of Next Generation T Cell Engager Platform

May 28, 2025

From CDR-Life

Via Business Wire

CDR-Life Presents Promising Preclinical Data for Novel T Cell Engager Programs at AACR Annual Meeting 2025

April 25, 2025

From CDR-Life

Via Business Wire

CDR-Life Demonstrates Commitment to Differentiated Pipeline with New Autoimmune Candidate CDR111

March 25, 2025

From CDR-Life

Via Business Wire

CDR-Life Announces Fifth Milestone Achievement with Boehringer Ingelheim in Geographic Atrophy

February 25, 2025

From CDR-Life

Via Business Wire

CDR-Life Appoints Sarah Holland, PhD, as Chief Business Officer

December 05, 2024

From CDR-Life

Via Business Wire

CDR-Life Announces Pipeline Progress of M-gager® Programs for Treatment of Solid Tumors

September 13, 2024

From CDR-Life

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.